Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
647
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
+8.28M
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
+$859M
-
Put/Call ratio
-
1.32
-
Number of buys
-
237
-
Number of sells
-
-302
-
Price
-
$100.20
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2025
807 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q3 2025.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 647 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (22.7M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (13.8M shares), JPMORGAN CHASE & CO (13.5M shares), CITIGROUP INC (10.9M shares), MORGAN STANLEY (10.6M shares), BANK OF AMERICA CORP /DE/ (9.4M shares), BNP PARIBAS FINANCIAL MARKETS (5.96M shares), WELLS FARGO & COMPANY/MN (2.78M shares), UBS Group AG (2.41M shares), and BARCLAYS PLC (2M shares).
This table shows the top 647 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.